Efficacy of afatinib for pulmonary adenocarcinoma with leptomeningeal metastases harboring an epidermal growth factor

Chunhua Ma1, Mei Liu, Ning Mu

  • 1Department of Intervention, Tianjin HuanHu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China.

Medicine
|October 30, 2020
PubMed
Abstract

Insights

This case report details a lung adenocarcinoma patient with leptomeningeal metastasis who improved with afatinib treatment targeting a complex epidermal growth factor receptor (EGFR) mutation. This highlights afatinib as a potential therapy for EGFR compound mutations in advanced lung cancer.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Liquid biopsy of cerebrospinal fluid (CSF) is an emerging tool for identifying actionable mutations in leptomeningeal metastasis.
  • Epidermal growth factor receptor (EGFR) mutations are crucial targets for personalized lung adenocarcinoma treatment.
  • Identifying complex EGFR mutations can guide therapy in advanced lung cancer with leptomeningeal spread.

Observation:

  • A patient with lung adenocarcinoma and leptomeningeal metastasis showed no response to standard therapies.
  • Next-generation sequencing of CSF identified a complex EGFR mutation (exon19del+K754E).
  • Afatinib treatment was initiated, with dose adjustment due to adverse effects.

Findings:

  • The patient experienced significant clinical improvement, including headache relief and reduced leptomeningeal enhancement on MRI.
  • Cerebrospinal fluid (CSF) pressure and tumor markers decreased.
  • Afatinib at a reduced dose demonstrated efficacy with manageable toxicity.

Implications:

  • This is the first report of clinical benefit from afatinib in lung adenocarcinoma with leptomeningeal metastasis and a complex EGFR mutation.
  • Afatinib provides a potential treatment option for patients with EGFR compound mutations.
  • This case underscores the value of liquid biopsy and targeted therapy in managing refractory leptomeningeal metastasis.